Private Client Services LLC Acquires Shares of 642 UnitedHealth Group Incorporated (NYSE:UNH)

Private Client Services LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 642 shares of the healthcare conglomerate’s stock, valued at approximately $338,000.

A number of other large investors also recently made changes to their positions in UNH. Robbins Farley acquired a new stake in UnitedHealth Group during the third quarter worth approximately $25,000. Richelieu Gestion SA acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $26,000. CGC Financial Services LLC boosted its holdings in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. NewSquare Capital LLC boosted its holdings in shares of UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA boosted its holdings in shares of UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH stock opened at $470.62 on Tuesday. The stock has a 50-day moving average price of $491.15 and a 200-day moving average price of $515.88. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The firm has a market cap of $433.88 billion, a PE ratio of 18.69, a price-to-earnings-growth ratio of 1.20 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.54 by $0.37. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period last year, the company posted $6.26 EPS. The business’s quarterly revenue was up 8.6% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.7 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.54%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Barclays assumed coverage on UnitedHealth Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 target price on the stock. Royal Bank of Canada reissued an “outperform” rating and set a $596.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 29th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Finally, Wells Fargo & Company cut their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $573.80.

Get Our Latest Stock Analysis on UNH

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.